Multipotent haematopoietic stem cells (HSCs) originate in the dorsal aorta (DA) during vertebrate embryogenesis and after migrating to a permanent niche in the bone marrow or equivalent, give rise to a continuous supply of mature blood cells of all lineages throughout adult life. Previous cell tracing experiments have shown that the cells of the DA and the HSCs, migrate here from an early collection of haemangioblasts (bipotential precursors of blood and endothelial cells) which reside in the dorsolateral plate (DLP) mesoderm. Development of HSCs is tightly regulated by a number of key signalling pathways in both the DLP and once the cells reach the midline. In particular, notch signalling is considered an important factor in HSC development and we know from studies in mice and zebrafish that notch is required for both arterial and HSC development. Here, we have used the relatively slow development and the spatial separation of definitive haematopoiesis from primitive haematopoiesis in Xenopus laevis embryos to reveal the first defect of reduced notch signalling in the haematopoietic system. Morpholino knock-down of notch1 or the notch target genes esr1 and hesr1, or the application of a potent γ-secretase inhibitor, DAPM, to Xenopus embryos leads to loss of HSC marker expression. Accompanying the loss of HSC expression we see maintenance of expression of specific endothelial genes, including the VEGF receptor, flk1. We show that notch1 is specifically required for the development of HSCs without affecting arterial or haemangioblast programming and thereby uncouple the notch contributions to arterial and HSC development. Here, for the first time, we also show that esr1 and hesr1 are required for the HSC programme. Embryonic hematopoiesis is an excellent model for understanding the complex decisions made by multi-potent progenitor cells toward precise and specific lineage differentiation. In zebrafish, Tbx16, a T-box transcription factor, is essential for appropriate embryonic erythropoiesis, as its loss-of-function mutant known as spadetail (spt) has virtually no embryonic erythrocytes. However, what genes lie downstream of Tbx16 and mediate its requirement for erythropoiesis is unknown. Here we report one such potential candidate els1, which is conserved in all vertebrates we investigated, but none of whose homologs have been experimentally examined for their function. els1 is expressed specifically in the intermediate mesoderm (IM), a transient embryonic tissue that gives rise to future pronephros, vasculature and blood, including embryonic erythrocytes; the expression peaks during early somitogenesis. This suggests that els1 is expressed in the right place and time for a role in erythropoiesis. This IM expression is virtually absent in a spt mutant, suggesting that els1 functions downstream of tbx16. Importantly, loss of els1 function (by way of morpholino injection) leads to a dramatic reduction of expression of the erythroid progenitor marker gene gata1, suggesting for the first time that els1 is required for appropriate embryonic erythropoiesis. The Els1 protein domain organization raises the possibility that Els1 may be a novel signaling molecule. In the near future, we propose to perform a structure-function study of the Els1 protein in vivo to shed light on the mechanism of its requirement for embryonic hematopoiesis. The Hospital for Sick Children, Toronto, ON, Canada
Myocardial progenitor development involves the migration of cells to the anterior lateral plate mesoderm (ALPM) where they are exposed to the necessary signals for differentiation. Whether the arrival of cells to this location is sufficient, or whether earlier signaling events are required, for progenitor development is poorly understood. Here we demonstrate that in the absence of Aplnr signaling, cells fail to migrate to the heart-forming region of the ALPM. Our work uncovers a previously uncharacterized cell-nonautonomous function for Aplnr signaling in cardiac development.
Furthermore, we show that both the single known Aplnr ligand, Apelin, and the canonical Gαi/o proteins that signal downstream of Aplnr are dispensable for Aplnr function. This work suggests a novel mechanism for Aplnr signaling in the establishment of a niche required for the proper migration/development of myocardial progenitor cells. Current work is focused on determining the alternate fate or location of cells destined for the heart-forming region in the absence of Aplnr signaling and when migration of these cells goes awry. The non-autonomous cue mediated by Aplnr signaling is also being investigated. doi:10.1016/j.ydbio.2011.05.233
Program/Abstract # 280 Cardiac BAF complex promotes heart progenitor differentiation and migration in the zebrafish embryo Xin Lou, Ian Scott Hospital for Sick Children, Toronto, ON, Canada
Congenital heart defects and adult-onset heart disease are among the most critical health problems in developed countries. A greater understanding of cardiac progenitor biology will ultimately be essential for regenerative and early-intervention therapeutic applications. At the onset of cardiomyocyte differentiation, a cardiac progenitor-specific gene expression module must somehow be initiated. This initial event must depend on appropriate epigenetic regulation activities, including chromatin-remodeling, which can modify DNA-histone interactions, thereby changing the availability of transcription factor binding sites. In eukaryotes, the BAF (Brg1 associated factor) complexes are large multi-subunit protein assemblies with chromatin-remodeling activities. These complexes can engage in a number of cell-specific events via differential use of variant subunits. Expression of Baf60c, a cardiac specific subunit of the BAF complex, with Gata4 and Tbx5 is sufficient to promote differentiation of mesodermal cells to cardiomyocytes in murine embryos. To uncover the endogenous role of this cardiac BAF (cBAF) complex in cardiac progenitors, we have used the zebrafish model. We first transplanted cells overexpressing gata5/baf60c to a wildtype host and found these cells could spontaneously migrate to the heartforming region and contribute to myocardium, endorcardium and smooth muscle at outflow tract. Remarkably, this occurred independent of the location cells were placed in the host. Further transplantation experiments using hosts with defects in various germ layers indicate that signal(s) emitted from the endoderm is dispensable for cBAF complex-driven cardiac progenitor migration and differentiation. Global overexpression of these three genes elevated the expression of heart-specific genes, resulting in an enlarged heart. In a fish embryonic cell culture/induction system the overexpression of cBAF also promoted differentiation of contractile cardiomyocyte. To determine the endogenous function of cBAF, baf60c together with gata5 and tbx5 were knocked down in the zebrafish embryo through morpholino injection. This led to massive downregulation of myocardial gene expression, with the morphants displaying severe heart defects. The ultimate fate of cBAF cells can be modulated, as shown by Fgf signaling inhibition leading to decreased myocardial, but not endocardial, differentiation of cBAF cells. Therefore, cBAF (Gata5/Smarcd3b) can promote formation of cells that home to the heart-forming region regardless of inhibitory signals in the embryo. As these cells can form all the lineages of the developing heart, these results show that cBAF can drive, in vivo, a CPC-like state. The mesothelium is an epithelial sheet that covers organs in the coelomic cavity and is involved in development of the vascular system. In the developing heart, the proepicardial organ (PE), migrates to and over the heart to form the epicardium, and undergoes epithelialmesenchymal transition (EMT) to give rise to the cells of the coronary blood vessels. The gut mesothelium (GM) serves as a major source of vascular smooth muscle cells for the gut tube in development. The role of mesothelial cells in both the heart and gut in the formation of blood vessels suggest that there may be similarities, possibly an interchangeable potential, in mesothelial development that exists among coelomic organs. To test the interchangeable potential of mesothelial cells, we used the chick-quail chimera system to transplant quail PEs into the peritoneal cavity of a chick embryo and quail GM cells into chick pericardial cavities. Our initial findings have revealed that both cell types have the potential to migrate into organs in the coelomic cavities, but PE cells do not incorporate into the endogenous GM, while GM cells will incorporate into the endogenous epicardium. However, in both systems, transplanted PE and GM cells become positive for smooth muscle. Taken together, our current data suggest that although the epicardium and GM appear similar in structure in the embryo and adult, and can potentially give rise to smooth muscle actin positive cells, we observe fundamental differences in how the mesothelium develops in the heart and gut. Many disorders are a direct result of the impaired development of the primitive gut tube, which is derived from the endodermal germ layer. Although the canonical Wnt pathway is central for many developmental processes, few studies have examined Wnt and its key player, β-catenin, in early endoderm specification. Similarly, Eomesodermin has only recently been implicated in definitive endoderm development. In addition, many of the genes that, in articulation with Eomesodermin, orchestrate trophectoderm lineage establishment in the early embryo, including Nodal, Cdx2, Fgf4 and Ascl2, will later prove decisive in initiating posterior endodermal fates and intestinal identity. In order to determine the role of β-catenin and Eomesodermin in the regional specification of gut endoderm progenitors, we designed a novel approach combining Cre-mediated mutagenesis and
